General Information
|
The Brazilian Journal of Pharmaceutical Sciences is published continually by the Faculty of Pharmaceutical Sciences of the University of São Paulo and has the objective of publishing the most recent advances in the Pharmaceutical Sciences Area. The Brazilian Journal of Pharmaceutical Sciences has its origin in 1939 with the publication of the "Anais de Farmácia e Odontologia da USP". In 1963, volume 1 of the journal name was changed to "Revista da Faculdade de Farmácia e Bioquímica da Universidade de São Paulo" and was published at that year. In 1970, the journal was again renamed as "Revista de Farmácia e Bioquímica da Universidade de São Paulo", name that was maintained until 1998. The Journal was totally remodeled and named as Revista Brasileira de Ciências Farmacêuticas/Brazilian Journal of Pharmaceutical Sciences in 1999. From 2009 on, celebrating 70 years of publishing, a new era started. The journal kept only the English denomination and at present accepts only papers in English. From 2019 the accepted papers entered into a continuous flow of publication. All these changes were made to increase the national and international visibility of the BJPS, speed the procedure of publication, towards consolidating the Journal as one of the main journals in the Pharmaceutical Sciences. The abbreviation is Braz. J. Pharm. Sci., which should be used in bibliographies, footnotes and bibliographical references and strips. |
Indexing sources
|
Impact Factor
|
Qualis - CAPES B1 |
Intellectual Property
|
All the contents of the Journal, except where identified, is licensed under a Creative Commons License by Attribution 4.0 Not Adapted (CC BY 4.0). The online journal has open and free access. |
CopyRight
|
The authors plight to send a signed document to the Brazilian Journal of Pharmaceutical Sciences, stating that the manuscript will not be simultaneously submitted to another Journal thereof. The authors sign stating his due participation on the paper in which his responsibility is made public, undertaking any legal lawsuits resulting from the inaccuracy of the former statement. The authors agree that, in case of having the article accepted, its copyright will be the sole property of the Brazilian Journal of Pharmaceutical Sciences, provided that its reproduction, partial or total, in any media, printed or electronic, without previous authorization is forbidden. |
Plagiarism
|
See item 3.d of the section “Scope and Politics”. |
Editorial Process
|
All manuscripts go through an initial evaluation that considers the presence of all attachments (figures, signed copyright form) and text format. If the manuscript is apt in this stage, then the Editor in Chief evaluates the quality of the content as well as if the scope and basic policies are in accordance. Then the manuscript goes through a single blind peer review. Later on, the Editor in chief decides on acceptance or rejection. |
Article Processing Charges (APCs)
|
There is no charges for article’s submissions, evaluations and publication. |
Complementary Information
|
This journal follows the principles of transparency and good practices in academic publications established by COPE, available in: https://publicationethics.org |
Sponsors
|
The Journal receives finnancial support from:
|
Editor in Chief & Scientific Editor
|
Co-Editors
|
Associated Editors
|
Editorial Advisory Board
|
Editorial Production
|
Technical and Administrative Support
|
Instructions to authors
| All details are available in Author’s Guideline document, available at: https://s3-us-west-2.amazonaws.com/clarivate-scholarone-prod-us-west-2-s1m-public/wwwRoot/prod4/societyimages/bjps-scielo/Guideline-guia%20autores2023.pdf |
Scope and politics
|
The purpose of the Brazilian Journal of Pharmaceutical Sciences is to publish manuscripts that significantly contribute to knowledge in all areas of Pharmaceutical Sciences, including:
Journal's policy, which are used as guidelines for the review of manuscripts:
The paper must report on recent advances in pharmaceutical technology, biopharmaceutics, pharmaceutical biotechnology, medication use, and pharmacist services of major importance.
Immediate rejection criteria: a. Description of analytical methods with no relation to pharmaceutics, biopharmaceutics, or pharmaceutical biotechnology. b. Mere description of compound synthesis, processes, validation, etc. without any pharmaceutical application. c. Inappropriate promotion of a trademark or a product. d. Regulatory issues with no relation to pharmaceutics, biopharmaceutics, or pharmaceutical biotechnology.
A paper must be based on a thorough and extensive study, using established or well-described methods and including proper controls. Research must be hypothesis-driven and conclusions must be supported by the data presented.
Immediate rejection criteria: a. No proof of concept in either an in vivo or an in vitro evaluation. b. No clear indication of the use of the product or formulation. c. No clear description of the materials & methods used in the pharmaceutical field. d. Use of inadequate or insufficient methods. e. Inappropriate statistical analysis. f. Lack of proper controls. g. Lack of coherent discussion of the results.
The study described in the manuscript must represent a novel approach.
Immediate rejection criteria a. Repetition of previously published data, either partially or entirely. b. Simple variation of parameters of a formulation, processes, synthesis, etc. c. Modification of well-known delivery systems with no novelty and/or benefit. d. Plagiarism (intentional and unacknowledged copying of other’s work) and self-plagiarism (re-use of parts of an author’s previously published work without proper attribution).
Before entering the review process, all manuscripts will go through a similarity check using the plagiarism detection software iThenticate. If the editors agree that there is a high percentage of similarity to other texts, the manuscript will be rejected immediately.
The following papers will not be accepted for publication: a. Studies on human subjects not approved by an accredited Ethics Committee or without written informed consent from the subject or legal guardian. b. Studies on animals not approved by an accredited Ethics and Animal Care Committee. c. Manuscripts describing plant extract activity that do not Identify quali and quantitative chemical markers of the extract.
Manuscript categories
Full-length Original Paper
Short Communication
Review Article
Concepts and Comments
Book Reviews |
Submitting manuscripts
|
Submission should be sent electronically through the ScholarOne system. If you need further assistance, please contact the Journal Staff (bjps@usp.br).
Additional informations: |
